Wellcome Connecting Science | Multi–omics in Metabolic Disease

Wellcome Connecting Science | Multi–omics in Metabolic Disease 7 June, 2023 - 9 June, 2023

Wellcome Genome Campus, Hinxton, CB10 1RQ, UK and virtual

Web Address



Deadline: 30/05/2023
Click here to register

Submit your abstract here

General Information

The vast burden of non-communicable diseases facing the world today is diet-related. This includes obesity, type 2 diabetes, dyslipidemia, and a whole host of other related metabolic disorders.  Although the prevalence is related to lifestyle, it is clear there are powerful genetic and other biological influences informing susceptibility to these conditions, which are inherently systemic disorders.

Great strides have been made in illuminating the complex pathophysiology of metabolic diseases, in large part due to the development and application of a whole repertoire of so-called ‘omics’ technologies. These include GWAS and genomics, epigenomics, transcriptomics, proteomics, metabolomics and lipidomics.

This meeting will gather international leaders in the field to update on the use of these ‘multi-omics’ approaches.  It further aims to improve inter-disciplinary knowledge-dissemination between scientists and clinicians working in basic and therapeutic research.

The programme will include short oral presentations selected from abstracts, lightning talks, posters, discussion sessions and networking opportunities for a highly interactive meeting.

Image copyright © Polygraph Design / BIH@Charité’ 

Deadline for submissions: 28 March 2023

Meeting organisers:

Wellcome Connecting Science



Karen Mohlke – University of North Carolina, USA

Eran Segal- Weizmann Institute of Science, Israel

Simon Anderson – University of West indies, West Indies

Melina Claussnitzer – Broad Institute, USA

Karine Clement – Sorbonne Univeristy, France

Segun Fatumo – Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Uganda

Matthias Mann – Max Planck Institute of Biochemistry, Germany

Eric Fauman – Pfizer, USA

Anna Gloyn – Stanford University, USA

Joanna Howson – Novo Nordisk Research Centre Oxford, UK

Anna Krook- Stanford University, USA

Jessica Lasky-Su – Harvard University, USA

Markus Ralser – Berlin Institute of Health at Charite, Germany

Tune Pers – University of Copenhagen, Denmark